Suppr超能文献

一种实用模型在预测中国肝细胞癌患者肝切除术后长期生存方面等同于BALAD或BALAD-2评分。

A Practical Model is Equivalent to the BALAD or BALAD-2 Score in Predicting Long-term Survival after Hepatectomy in Chinese Patients with Hepatocellular Carcinoma.

作者信息

He Hua, Ji Bai, Jia Zhifang, Zhang Yangyu, Wang Xueying, Tao Xuerong, Liu Yahui, Jiang Jing

机构信息

Division of Clinical Research, the First Hospital of Jilin University, Changchun 130021, Jilin Province, China.

Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, Jilin Province, China.

出版信息

J Cancer. 2021 Jan 1;12(5):1474-1482. doi: 10.7150/jca.51593. eCollection 2021.

Abstract

To evaluate the predictive value of the BALAD and BALAD-2 scores on long-term survival after hepatectomy in Chinese hepatocellular carcinoma (HCC) patients and to attempt to establish a more practical or effective model. A total of 251 HCC patients underwent hepatectomy were recruited. The BALAD and BALAD-2 scores were calculated with total bilirubin, albumin, alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin. The associations of the two scores and their components with the overall survival were analyzed. Finally, three prediction models were explored and constructed. We observed that HCC patients had 5-year survival rates that worsened with increasement of BALAD and BALAD-2 scores. The BALAD and BALAD-2 scores demonstrated fine value in predicting overall survival with Harrell-C statistics of 0.665 (0.618-0.712) and 0.603 (0.554-0.636). After two variables, largest tumor size and BMI, were included in BALAD [0.720 (0.671-0.769)] or BALAD-2 [0.701 (0.649-0.751)] multivariate models, the Harrell-C statistic increased significantly than BALAD (=0.048) or BALAD-2 (<0.001) alone. Taking into account availability and expense, an equivalent BAA-BS model was established based on total bilirubin, albumin, AFP, BMI and largest tumor size. The Harrell-C statistic of BAA-BS model [0.723(0.674-0.772)] was similar to that of BALAD (=0.820) or BALAD-2 (=0.209) multivariate model. And, the continuous net reclassification index and integrated discriminatory improvement were not statistically different. Finally, a nomogram of the equivalent BAA-BS model was constructed to assist surgeons and patients in predicting 5-year survival rates. Both BALAD and BALAD-2 scores were highly suitable for predicting long-term survival after hepatectomy in Chinese HCC patients. A significant increase in predictive efficacy was observed after the addition of largest tumor size and BMI to BALAD or BALAD-2 score. Even if AFP-L3 and DCP are not detected, an equivalent BAA-BS model also obtained an excellent discriminatory performance.

摘要

评估BALAD和BALAD-2评分对中国肝细胞癌(HCC)患者肝切除术后长期生存的预测价值,并尝试建立一个更实用或有效的模型。共纳入251例行肝切除术的HCC患者。使用总胆红素、白蛋白、甲胎蛋白、甲胎蛋白的豆凝集素反应性部分和异常凝血酶原计算BALAD和BALAD-2评分。分析了这两个评分及其各成分与总生存期的相关性。最后,探索并构建了三个预测模型。我们观察到,HCC患者的5年生存率随着BALAD和BALAD-2评分的增加而恶化。BALAD和BALAD-2评分在预测总生存期方面显示出良好价值,Harrell-C统计量分别为0.665(0.618 - 0.712)和0.603(0.554 - 0.636)。在将最大肿瘤大小和BMI这两个变量纳入BALAD [0.720(0.671 - 0.769)]或BALAD-2 [0.701(0.649 - 0.751)]多变量模型后,Harrell-C统计量比单独的BALAD(=0.048)或BALAD-2(<0.001)显著增加。考虑到实用性和费用,基于总胆红素、白蛋白、甲胎蛋白、BMI和最大肿瘤大小建立了等效的BAA-BS模型。BAA-BS模型的Harrell-C统计量[0.723(0.674 - 0.772)]与BALAD(=0.820)或BALAD-2(=0.209)多变量模型相似。并且,连续净重新分类指数和综合鉴别改善无统计学差异。最后,构建了等效BAA-BS模型的列线图,以帮助外科医生和患者预测5年生存率。BALAD和BALAD-2评分都非常适合预测中国HCC患者肝切除术后的长期生存。在BALAD或BALAD-2评分中加入最大肿瘤大小和BMI后,预测效能显著提高。即使未检测到甲胎蛋白-L3和异常凝血酶原,等效的BAA-BS模型也获得了出色的鉴别性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cf0/7847645/cbd557d37567/jcav12p1474g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验